Clinical Trial Update: Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating enoxaparin to prevent radial artery occlusion after transradial access hepatic arterial infusion chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radial Artery Occlusion

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Zhongshan Hospital (Xiamen), Fudan University | Conditions: Radial Artery Occlusion | Phase 2 | Status: UNKNOWN